A 2019 preclinical study published in Neuropharmacology found Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) demonstrated BDNF receptor potentiation seven orders of magnitude greater than BDNF itself
This involves migrating neural stem cells originating from the sub-ventricular zone (SVZ) and the sub-granular zone (SGZ) of the dentate gyrus [34,342,343] to the infarct and peri-infarct region, followed by their differentiation into functional neurons [344,345,346], as shown in Figure 15 [9,12]
Common signs include persistent fatigue (even after a full nights sleep), brain fog, mood swings or irritability, numbness or tingling in the hands or feet, and a weakened immune system
These agents target specific chemicals in the body to prevent them from acting on the joints